Back

Journal of Clinical Virology

54 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Comparative analytical sensitivity evaluation of five mpox point-of-care assays for mpox clades Ia, Ib, IIa and IIb
2026-01-19 infectious diseases 10.64898/2026.01.17.26344231
#1 (7.1%)
Show abstract

BackgroundsFollowing an increase in mpox clade Ib cases in several African countries, the World Health Organization recognized mpox as a public health emergency of international concern, highlighting the need for reliable and accessible diagnostic tools. As several mpox clades are co-circulating in endemic countries, the analytical sensitivity of diagnostic assays should be evaluated for all of them in a comparative manner. MethodsThis study evaluated the analytical sensitivity of three rapid t...

2
Analytical Performance of the AMDI Fast PCR Mini Respiratory Panel
2025-12-29 infectious diseases 10.64898/2025.12.22.25342853
#1 (6.4%)
Show abstract

Influenza A, Influenza B, SARS-CoV-2, Respiratory Syncytial Virus and other respiratory pathogens are an ongoing public health concern. The ability to rapidly identify these viruses early in infection is essential for effective treatment and outbreak control. The AMDI Fast PCR Mini Respiratory Panel (MRP) incorporates sample preparation and real-time RT-PCR for detection of Flu A, Flu B, SARS-CoV-2 and RSV from anterior nasal swab (ANS) specimens in less than 10 minutes at the point of care. We ...

3
Prospective Multicenter Evaluation of the QuickNavi-Campylobacter Assay in Stool Specimens
2026-03-04 infectious diseases 10.64898/2026.03.03.26346362
Top 0.2% (5.8%)
Show abstract

The rapid diagnosis of Campylobacter infections is important for the management of infectious gastroenteritis. Although stool culture is considered the gold standard, its sensitivity is limited and it requires prolonged incubation times. We performed a prospective multicenter study at nine healthcare facilities in Japan to evaluate a Campylobacter rapid antigen test using stool specimens between March 2024 and August 2025. Patients with suspected infectious gastroenteritis were consecutively enr...

4
Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B and SARS-CoV-2
2025-12-30 infectious diseases 10.64898/2025.12.29.25343166
Top 0.3% (5.4%)
Show abstract

Over-the-counter (OTC) lateral flow tests for respiratory viruses have newly emerged since the beginning of the coronavirus disease 2019 (COVID-19) pandemic and are increasingly available to consumers. While all marketed tests have met standards for Emergency Use Authorization (EUA), De Novo classification or 510(k) clearance, limited data are available to inform consumers of their relative performance. We performed a head-to-head benchtop analytical assessment of OTC tests available for purchas...

5
Clinical validation of a novel metagenomic nanopore sequencing method for detecting viral respiratory pathogens
2026-02-07 infectious diseases 10.64898/2026.02.06.26345651
Top 0.4% (4.8%)
Show abstract

BackgroundClinical metagenomics (CMg) offers high-throughput respiratory pathogen detection with a wider range than targeted, probe-dependent diagnostics. Sequencing cost and the challenges of high host biomass in non-invasive samples are barriers to the use of CMg in high-throughput respiratory pathogen detection. MethodsWe optimised a long-read sequencing workflow to detect RNA viruses in nasopharyngeal swabs, employing pathogen enrichment and ONT sequencing. As a pre-requisite for agnostic p...

6
Comparative evaluation of EUCAST RAST and QuickMIC for rapid susceptibility testing of carbapenem-resistant organisms directly from positive blood cultures
2026-01-26 infectious diseases 10.64898/2026.01.23.26344696
Top 0.7% (4.0%)
Show abstract

ObjectiveThe rapid availability of phenotypic antimicrobial susceptibility results is crucial for the timely detection of multidrug-resistant Gram-negative organisms and for guiding optimized treatment strategies. Recently, novel methods have been introduced that enable direct antimicrobial susceptibility testing (AST) from positive blood cultures. However, their performance has not yet been systematically compared in head-to-head evaluations. This study aimed to assess the analytical performanc...

7
Feasibility and Performance of Procalcitonin-guided antimicrobial stewardship during autologous stem cell transplantation
2025-12-16 infectious diseases 10.64898/2025.12.15.25340973
Top 0.8% (3.8%)
Show abstract

BackgroundAntibiotic stewardship during stem cell transplantation (SCT) is challenging.. Procalcitonin (PCT) has been employed successfully in critical care patients to safely guide stewardship. However, procalcitonin guided stewardship has not been robustly assessed in SCT recipients. We sought to evaluate the potential utility of PCT to guide antimicrobial de-escalation during engraftment. Methods100 SCT patients were prospectively enrolled in a "strategy trial" and had infectious complicatio...

8
A Case Report Describing a Persistent SARS-CoV-2 Infection Outcomes and Mutations Associated with B-cell Deficiency
2026-02-17 infectious diseases 10.64898/2026.02.13.26346281
Top 0.9% (3.7%)
Show abstract

BackgroundImmunocompromised (IC) individuals are at increased risk for persistent SARS-CoV-2 infections and can develop new viral mutations and lineages not seen in the community. In this case report, a persistent SARS-CoV-2 infection (330 days) in an IC patient is examined for viral mutations and mutations associated with cryptic lineages. Case PresentationThe patient was followed in a longitudinal study examining persistent SARS-CoV-2 in IC patients. The patient provided stool and nasal swab ...

9
A novel RNA nucleic acid amplification test more accurately distinguishes active Clostridioides difficile infection from colonization
2026-02-06 infectious diseases 10.64898/2026.02.05.25342495
Top 0.9% (3.7%)
Show abstract

Clostridioides difficile (C. diff) is a leading cause of hospital-acquired infections with severity ranging from mild diarrhea to fulminant colitis and death. Current antigen tests lack adequate sensitivity and DNA-based nucleic acid amplification tests (DNA-NAATs) exhibit limited specificity for active infection, leading to either underdiagnosis or inappropriate treatment of colonized individuals. Unlike DNA, mRNA is expressed only by metabolically active bacteria and is rapidly hydrolyzed, pro...

10
Biologically contained Ebola virus enables standardised neutralisation testing for preclinical and clinical immunogenicity assessment
2026-02-07 infectious diseases 10.64898/2026.02.06.26345727
Top 1.0% (3.6%)
Show abstract

BackgroundNeutralising antibody titres are widely used as key immunogenicity endpoints in Ebola virus (EBOV) vaccine and monoclonal antibody clinical trials. However, direct comparison of results across studies remains challenging due to the use of heterogeneous neutralisation platforms, ranging from pseudotyped viruses to live EBOV assays. These limitations restrict assay standardisation, validation, scalability, and compliance with good clinical laboratory practice (GCLP), particularly in outb...

11
Analytical Sensitivity of the BOSCH Vivalytic Molecular Assay for Detection of Monkeypox Virus Clade Ib
2026-01-11 infectious diseases 10.64898/2026.01.07.25342807
Top 1.0% (3.6%)
Show abstract

We evaluated the BOSCH Vivalytic MPXV assay using serial dilutions of monkeypox virus clade Ib, a new offshoot of clade I identified in 2023. The assay detected viral DNA down to [~]100 copies/mL demonstrating comparable analytical sensitivity to our in-house reference PCR and to other commercial platform-based mpox molecular assays.

12
Global performance of Human Papillomavirus Typing, Screening, and Evaluation as assessed using Proficiency Panels traceable to International Standards
2026-01-05 infectious diseases 10.64898/2026.01.03.26343391
Top 1% (3.5%)
Show abstract

BackgroundAccurate and comparable human papillomavirus (HPV) testing is essential for HPV vaccine research, HPV surveillance, and cervical cancer screening. In 2008, the WHO HPV Laboratory Network initiated global HPV proficiency testing traceable to International Standards (IS), which has been issued regularly since. Here, we summarize recent results and trends over time. MethodsThe HPV genotyping panel, used since 2008, consists of 43 blinded samples, including HPV 6, HPV 11, all oncogenic an...

13
Diagnostic Potential for IgM Antibody Detection by the DPP Syphilis TnT Assay in Neonates at Risk for Congenital Syphilis
2026-01-06 infectious diseases 10.64898/2026.01.05.26343454
Top 1% (2.8%)
Show abstract

BackgroundNeonatal IgM antibodies reflect an in-utero immune response to Treponema pallidum and may offer added diagnostic value. This study evaluated the test performance of treponemal IgM levels measured by the research-use-only (RUO) DPP Syphilis TnT point-of-care (POC) assay for CS risk stratification. MethodsConducted from May 2023 to May 2025, this study tested neonatal serum samples from infants born to mothers with syphilis using the DPP Syphilis TnT RUO POC assay, which reports trepone...

14
Genetic characterization of a Citrobacter braakii isolate possessing blaNDM-1 obtained from toilet bowl water in a tertiary healthcare-associated facility in North Macedonia.
2026-02-05 infectious diseases 10.64898/2026.02.03.26345508
Top 1% (2.8%)
Show abstract

Carbapenem-resistant (CR) bacteria have emerged and been spreading beyond healthcare-associated facilities into the environment. It is recognized that toilet bowl water in patient rooms of healthcare-associated facilities can be one of internal reservoirs of CR bacteria. In accordance with this idea, toilet bowl water samples were collected from patient rooms in a tertiary healthcare-associated facility in North Macedonia, and meropenem (MEM)-resistant bacterial isolates were obtained from the t...

15
Development and Validation of a Pan-Plasmodium Molecular Assay as a Confirmatory Method for Malaria Blood Donor Screening
2025-12-23 infectious diseases 10.64898/2025.12.22.25342854
Top 1% (2.6%)
Show abstract

BackgroundTransfusion-transmitted malaria remains a concern in non-endemic regions due to asymptomatic parasitemia in donors with prior residence in or travel to malaria-endemic areas. Nucleic acid testing (NAT)-based screening has been proposed to mitigate this risk, and supplemental assays are needed to confirm reactive donations. We developed a pan-Plasmodium reverse transcription quantitative PCR (RT-qPCR) assay with species identification capability as a supplemental tool for malaria donor ...

16
Clinical Performance of a Mp1p Antibody Detection Immunoassay For Talaromycosis
2026-02-14 infectious diseases 10.64898/2026.02.08.26344333
Top 1% (2.6%)
Show abstract

BackgroundTalaromycosis, caused by the fungus Talaromyces marneffei, is a leading cause of HIV-associated death in Southeast Asia. Current culture-based diagnosis only identifies late-stage infection, limiting understanding of disease burden and disease spectrum. We evaluated the clinical performance of anti-Mp1p IgM and IgG enzyme immunoassays (EIA) for talaromycosis diagnosis. MethodsThis diagnostic study included 423 adults with advanced HIV disease and culture-confirmed talaromycosis as cas...

17
Mass-Standardised IgG Response to Fourteen SARS-CoV-2 Spike Protein variants and Antibody Subclass analysis for IgG subclasses and IgE for a Long COVID Patient Cohort
2026-01-27 infectious diseases 10.64898/2026.01.26.26344863
Top 2% (2.5%)
Show abstract

A multivariant total subclass analysis has been performed for a control cohort (n=15) and a long COVID patient cohort (n=15) measuring the IgG1, IgG2, IgG3, IgG4 and IgE response to the following 14 variants of SARS-CoV-2: Wuhan, Alpha, Delta, BA.1, BA.2, BA.5, EG.5.1, XBB.1.5, BA.2.75, CH.1.1, BA.2.12.1, BQ.1.1, JN.1, and KP.3. Significant differences (p < 0.05 and p < 0.005) between concentrations of IgG subclasses by variant were found in 24% of variants and in mean-normalised distributions. ...

18
Comparative Analysis of Biofilm Formation in Bacterial and Fungal Isolates from Contact Lens and Non-Contact Lens Associated Keratitis
2026-02-09 infectious diseases 10.64898/2026.02.09.26345896
Top 2% (2.0%)
Show abstract

Microbial keratitis is a sight-threatening corneal infection with varying etiological agents, primarily bacteria and fungi. Assessing and contrasting the virulence factors of microorganisms isolated from a non-contact lens-associated keratitis (NCLAK) and contact lens-associated keratitis (CLAK) is the goal of the current investigation. Samples were collected from over 60 patients and analysed using standard microbiological techniques, including culture, Gram staining, KOH mount, biochemical tes...

19
Pretransplant and posttransplant erythroferrone levels and outcomes after heart transplantation
2026-02-24 transplantation 10.64898/2026.02.20.26346755
Top 2% (1.9%)
Show abstract

BackgroundIron metabolism disorder is highly prevalent before and after heart transplantation (HTx). The impact of pretransplant and posttransplant iron disorder on posttransplant outcomes is unclear. ObjectivePretransplant serum levels of key regulator proteins of iron metabolism (hepcidin, interleukin-6, erythroferrone) were tested for prediction of the composite outcome 1-year posttransplant all-cause mortality (ACM) or [&ge;]moderate acute cellular rejection (ACR). Furthermore, serum levels...

20
All text: A Novel Scoring System for Precise Severity Quantification in Severe Fever with Thrombocytopenia Syndrome: Development and Application Based on Dynamic Clinical Data
2026-02-18 infectious diseases 10.64898/2026.02.17.26346452
Top 2% (1.9%)
Show abstract

BackgroundSevere Fever with Thrombocytopenia Syndrome (SFTS) is an acute infectious disease with high mortality. This study aimed to develop a quantitative scoring system for grading SFTS severity using dynamic clinical data. MethodsA retrospective study included 547 confirmed SFTS patients from two hospitals. Clinical data were collected over a 14-day course (divided into four phases). Patients were grouped into survivors (n=451) and non-survivors (n=96). Statistical analyses, including Kaplan...